In the last trading session, 1.23 million Mersana Therapeutics Inc (NASDAQ:MRSN) shares changed hands as the company’s beta touched 1.54. With the company’s per share price at $3.79 changed hands at -$0.02 or -0.52% during last session, the market valuation stood at $459.73M. MRSN’s last price was a discount, traded about -153.83% off its 52-week high of $9.62. The share price had its 52-week low at $0.80, which suggests the last value was 78.89% up since then. When we look at Mersana Therapeutics Inc’s average trading volume, we note the 3-month average coming to 2.17 million.

Mersana Therapeutics Inc (NASDAQ:MRSN) trade information

Instantly MRSN was in red as seen at the end of in last trading. With action -8.89%, the performance over the past five days has been red. The drop to weekly highs of 4.18 subtracted -0.52% to the stock’s daily price. The company’s shares are showing year-to-date upside of 63.36%, with the 5-day performance at -8.89% in the red. However, in the 30-day time frame, Mersana Therapeutics Inc (NASDAQ:MRSN) is -24.28% down.

Mersana Therapeutics Inc (MRSN) estimates and forecasts

Data shows that the Mersana Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 163.19% over the past 6 months, a 59.46% in annual growth rate that is considerably higher than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.93%. The 2024 estimates are for Mersana Therapeutics Inc earnings to increase by 55.53%.

MRSN Dividends

Mersana Therapeutics Inc is expected to release its next quarterly earnings report in May.